These findings demonstrate that NEAT1 promotes hepatocellular carcinoma, both in vitro and in vivo, by downregulating miRNA 22 3p and preventing it from suppressing AKT2 expression [95,96]. This evidence concerns the gene AKT2 and hepatocellular carcinoma.